News Website

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced or recurrent endometrial cancer in Japan - springermedicine.com

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced …

Published: Dec. 28, 2024, 12:47 p.m.

Read Full Article

TEFM facilitates uterine corpus endometrial carcinoma progression by activating ROS-NFκB pathway - Journal of Translational Medicine

TEFM facilitates uterine corpus endometrial carcinoma progression by activating ROS-NFκB pathway Journal of Translational Medicine

Published: Dec. 27, 2024, 1:02 p.m.

Read Full Article

Unlocking the Future of Medicine! Discover the Secrets of Red Biotechnology! - Clinique Bio

Unlocking the Future of Medicine! Discover the Secrets of Red Biotechnology! Clinique Bio

Published: Dec. 25, 2024, 11:14 p.m.

Read Full Article

Unlocking the Future of Medicine! Discover the Secrets of Red Biotechnology! - cliniquebio.com

Unlocking the Future of Medicine! Discover the Secrets of Red Biotechnology! cliniquebio.com

Published: Dec. 25, 2024, 11:14 p.m.

Read Full Article

Telomere length in relation to fecundability and use of assisted reproductive technologies: the Norwegian Mother, Father, and Child Cohort Study - BMC Medicine

Telomere length in relation to fecundability and use of assisted reproductive technologies: the Norwegian Mother, Father, and Child Cohort Study BMC Medicine

Published: Dec. 18, 2024, 8:05 p.m.

Read Full Article

Press Release Service: Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial - CRISPR Medicine News

Press Release Service: Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial CRISPR Medicine News

Published: Dec. 13, 2024, 12:56 p.m.

Read Full Article

Endometriosis and uterine fibroids associated with a greater risk of mortality due to gynecologic cancers - 2 Minute Medicine

Endometriosis and uterine fibroids associated with a greater risk of mortality due to gynecologic cancers 2 Minute Medicine

Published: Nov. 30, 2024, 12:15 a.m.

Read Full Article

Endometriosis Market expected to rise | Companies – AbbVie, Neurocrine Biosciences, ObsEva, Kissei Pharmaceuticals, SWK, Enteris BioPharma, Bayer, Hope Medicine, Tiumbio, Organon, expected to drive mar - Barchart

Endometriosis Market expected to rise | Companies – AbbVie, Neurocrine Biosciences, ObsEva, Kissei Pharmaceuticals, SWK, Enteris BioPharma, Bayer, Hope Medicine, Tiumbio, Organon, expected to drive mar Barchart

Published: Nov. 26, 2024, 9:03 p.m.

Read Full Article

2 Minute Medicine Rewind November 25, 2024 - 2 Minute Medicine

2 Minute Medicine Rewind November 25, 2024 2 Minute Medicine

Published: Nov. 25, 2024, 11:08 a.m.

Read Full Article

Transcriptomics of tissue exosomes to investigate miR-195-5p’s amelioration of endometrial fibrosis via the YAP-Smad7 pathway: an animal study - Journal of Translational Medicine

Transcriptomics of tissue exosomes to investigate miR-195-5p’s amelioration of endometrial fibrosis via the YAP-Smad7 pathway: an animal study Journal of Translational Medicine

Published: Nov. 21, 2024, 10:05 a.m.

Read Full Article

Latest Articles

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced or recurrent endometrial cancer in Japan - springermedicine.com

TEFM facilitates uterine corpus endometrial carcinoma progression by activating ROS-NFκB pathway - Journal of Translational Medicine

Unlocking the Future of Medicine! Discover the Secrets of Red Biotechnology! - Clinique Bio

Unlocking the Future of Medicine! Discover the Secrets of Red Biotechnology! - cliniquebio.com

Telomere length in relation to fecundability and use of assisted reproductive technologies: the Norwegian Mother, Father, and Child Cohort Study - BMC Medicine

Press Release Service: Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial - CRISPR Medicine News

Endometriosis and uterine fibroids associated with a greater risk of mortality due to gynecologic cancers - 2 Minute Medicine

Endometriosis Market expected to rise | Companies – AbbVie, Neurocrine Biosciences, ObsEva, Kissei Pharmaceuticals, SWK, Enteris BioPharma, Bayer, Hope Medicine, Tiumbio, Organon, expected to drive mar - Barchart

2 Minute Medicine Rewind November 25, 2024 - 2 Minute Medicine

Transcriptomics of tissue exosomes to investigate miR-195-5p’s amelioration of endometrial fibrosis via the YAP-Smad7 pathway: an animal study - Journal of Translational Medicine

Subscribe to Our Newsletter